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Novel Functional Role of NK3R 
Expression in the Potentiating 
Effects on Somatolactin α 
Autoregulation in grass  
carp pituitary cells
Guangfu Hu1,2, Mulan He2 & Anderson On Lam Wong2
In our previous study, NKB/NK3R system has been shown to act at the pituitary level to up-regulate 
SLα synthesis and secretion in grass carp. However, whether NK3R expression can serve as a regulatory 
target at the pituitary level and contribute to NKB interactions with other SLα regulators is still unclear. 
In current study, using grass carp pituitary cells as a model, we have a novel finding that co-treatment 
of SLα/SLβ with carp TAC3 gene products, could induce a noticeable enhancement in SLα mRNA 
expression and these potentiating effects occurred with a parallel rise in NK3R transcript level after 
SLα/SLβ treatment. Interestingly, the stimulatory effects of SLα/SLβ on NK3R gene expression could 
be further potentiated by co-treatment with IGF-I/-II and simultaneous exposure of carp pituitary cells 
to SLα/SLβ and IGF-I/-II in the presence of TAC3 gene products was found to markedly elevated SLα 
mRNA expression (20 fold increase) and this synergistic stimulation was mediated by cAMP/PKA-, PLC/
PKC- and Ca2+ -dependent cascades functionally coupled with NK3R activation. These findings suggest 
that local release of SLα via functional interactions with IGF-I/-II and TAC3/NK3R system may constitute 
a potent stimulatory signal for SLα gene expression in the carp pituitary via up-regulation of NK3R 
expression.
Somatolactin (SL), the latest member of growth hormone (GH)/prolactin (PRL) family, is a fish-specific hormone 
released from the neurointermediate lobe (NIL) of the posterior pituitary1. Two isoforms of SL, SLα and SLβ , 
have been identified in fish pituitary, e.g., in zebrafish2, salmon3, and grass carp4, and suspected to have over-
lapping and yet distinct functions5. To date, SL has been shown to be involved in diverse functions in fish mod-
els, including chromatophore proliferation and differentiation6, pigment aggregation7, inflation of swim bladder 
during embryo development5, reproduction3, stress responses8, lipid metabolism9, and osmoregulation10. At the 
pituitary level, somatolactin secretion and gene expression are known to be under the control by various hypo-
thalamic factors, e.g., dopamine11, GnRH12,13, PACAP4, neurokinin B (NKB)14, MCH15 and octadecdaneuropep-
tide16. Recently, insulin-like growth factors (IGFs) have also been identified as potent stimulators for SLα and SLβ 
secretion and gene expression in grass carp pituitary cells17. At the pituitary level, “somatolactin autoregulation” 
via autocrine/ paracrine effects of SLα and SLβ released locally within the pituitary has also been reported in grass 
carp7. However, the functional interactions of local release of SL with other SL regulators have not been examined 
and still awaited for further investigation.
NKB is the gene product of tachykinin 3 (TAC3), which is a member of the tachykinin family with pleiotropic 
functions, including the control of smooth muscle contraction in the gastrointestinal tract18, fluid secretion in the 
gut epithelium19, vasodilating effect for blood pressure modulation20 and stimulating effect on sperm movement21. 
The biological actions of NKB are mediated mainly by the Type 3 neurokinin receptor (NKR), namely NK3R, 
which is a member of the rhodopsin-type class I group G protein coupled receptor22 and functionally coupled 
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with cAMP/PKA-23, PLC/IP3/PKC-24, and Ca2+ -dependent25 signaling pathways. In recent years, the functional 
role of NKB in puberty onset26 and human fertility has aroused a lot of interest in the field of reproductive biology, 
mainly due to the findings that loss-of-function mutations in NKB or its receptor NK3R can lead to hypogon-
adotropic hypogonadismor and even infertility in human subjects27–29. Based on the studies in mammals (e.g., 
rodent and sheep), NKB was found to be a key regulator for GnRH pulsatility and downstream LH release via 
NK3R activation in kisspeptin neurons located in the arcuate nuclei within the hypothalamus30,31. Similar inves-
tigations have been recently extended to fish models with the novel findings that the TAC3 gene in fish species, 
e.g., in zebrafish32–34, goldfish35, tilapia36 and grass carp14, not only encodes NKB as the gene product, but also the 
mature peptide of a new member of tachykinin called NKB-related peptide (NKBRP). Similar to NKB, NKBRP 
was also effective in stimulating LH release, e.g., in zebrafish32, goldfish35 and tilapia36, suggesting the reproductive 
function of TAC3 gene products was well conserved throughout vertebrate evolution. Based on our recent in vitro 
studies in grass carp pituitary cells, interestingly, NKB and NKBRP were found to have no effect on LH secretion 
and LHβ & GtHα gene expression at the pituitary level but rather serve as novel stimulators for prolactin (PRL) 
and SLα secretion and gene expression via differential activation of NK2R and NK3R expressed in the carp pitui-
tary14. The investigation on SLα regulation by TAC3 gene products in the carp model have become more exciting 
with the recent demonstration that IGF-I/-II could act in a synergistic manner with TAC3 gene products, namely 
NKB and NKBRP, to up-regulate SLα gene expression at the pituitary level and this potentiating effect could 
be paralleled with the concurrent rise in NK3R expression induced by IGF-I/-II treatment. These new findings 
demonstrated for the first time that NK3R expression at the pituitary level could serve as a regulatory target for 
modulation of pituitary hormone gene expression in vertebrate species.
In this study, using primary culture of grass carp pituitary cell as a model, the functional interactions between 
somatolactin autoregulation with IGF-I/-II and TAC3 gene products on SLα gene expression were examined in 
the carp pituitary with focus on the role of NK3R expression as a regulatory target at the pituitary level. As a first 
step, co-treatment of SLα /SLβ with either IGF-I/-II alone or TAC3 gene products alone including NKBa and 
NKBRPa (the gene products of carp TAC3a gene) or with a combination of both were performed to examine their 
effects on SLα mRNA expression in carp pituitary cells. The potentiating effects observed with SL/IGFs and SL/
TAC3 gene product co-treatment on SLα gene expression were correlated with parallel changes of NK3R mRNA 
expression induced by SLα /SLβ treatment alone or in combination with IGF-I/-II co-treatment. Using a phar-
macological approach, the signal transduction mechanisms involved in SLα and SLβ induction of NK3R mRNA 
expression were elucidated and the functional role of NK3R expression and the post-receptor signaling pathways 
coupled with NK3R activation in the potentiating effects on SLα mRNA expression observed with cotreatment 
of IGF-I/-II and TAC3 gene products was also confirmed at the pituitary cell level. Our studies for the first time 
provide evidence that local release of SLα and SLβ could interact with IGF-I/-II and TAC3 gene products to 
up-regulate SLα gene expression in the carp pituitary via stimulation of NK3R expression at the pituitary level.
Results
Synergistic effects of somatolactin and TAC3a gene products on SLα mRNA expression. Given 
that (i) two somatolactin isoforms, SLα and SLβ , have been previously shown to trigger SLα secretion and gene 
expression at the pituitary level7, and (ii) TAC3a gene products could also stimulate SLα secretion and gene 
expression via activation of NK3R in carp pituitary cells14, we examined the functional interaction between 
TAC3a gene products and SLs in their stimulatory activity on SLα gene expression. As shown in Fig. 1a, static 
incubation with SLα (30 nM) and NKBRPa (1 μ M) alone were both effective in elevating SLα mRNA expres-
sion in carp pituitary cells in a time-dependent fashion. Interestingly enough, the stimulatory effect on SLα 
mRNA expression was markedly enhanced (up to 8 fold basal) especially after 24–48 hr of drug treatment with 
simultaneous exposure to both SLα (30 nM) and NKBRPa (1 μ M). In the single-dose experiment with drug 
treatment fixed at 24 hr, the potentiating effect (up to 8 fold basal) could still be observed with co-treatment 
of either SLα or SLβ (30 nM) with the carp TAC3a gene products including NKBa (1 μ M) and NKBRPa (1 μ 
M), respectively (Fig. 1b). In the parallel experiments, the synergistic action between NKBRPa and SLα was 
also confirmed by a concentration-response study. As shown in Fig. 1c, NKBRPa (1 μ M)-induced SLα mRNA 
expression was found to be aggravated in a dose-dependent manner with cotreatment of increasing level of 
SLα (0.01–100 nM). Similar dose-dependence of the potentiating effect was also noted in the reciprocal exper-
iment with cotreatment of SLα (30 nM) with increasing levels of NKBRPa (0.1–1000 nM). In the case of SLβ 
regulation, IGF-I, SLα and SLβ alone could all trigger SLβ mRNA expression in grass carp pituitary cells, 
but static incubation with NKBa or NKBRPa were both not effective in elevating SLβ mRNA expression and 
secretion significantly. In addition, cotreatment with NKBa/NKBRPa and SLα could not potentially increase 
SLβ transcript levels (Fig.S1). To establish the functional link between SLα potentiation and NK3R at the pitu-
itary level, the NK3R agonist senktide (1 μ M) was substituted for NKBa and NKBRPb in the potentiating study 
with SLα co-treatment. As shown in Fig. 1d, NK3R activation with senktide was found to mimic the syner-
gistic effects of TAC3a gene products on SLα mRNA expression when give together with either SLα (30 nM) 
or SLβ (30 nM). Besides, co-treatment with NK3R antagonist SB222200 (10 μ M) not only could reduce the 
stimulatory actions on SLα mRNA expression induced by SLα (30 nM)/SLβ (30 nM) and NKBRPa (1 μ M) 
alone, but also significantly suppressed the potentiating effect induced by SLα /SLβ and NKBRPa co-treatment 
(Fig. 1e). These results indicated that the synergistic effect of SL and TAC3 gene products on SLα mRNA expres-
sion is dependent on NK3R activation.
Up-regulation of NK3R gene expression by SLα/β in grass carp pituitary cells. According to our 
previous study, IGFs could strongly enhance NKB-induced SLα mRNA expression through the up-regulation 
of NK3R expression in carp pituitary cells. To test the hypothesis that NK3R modulation may have occurred 
during SL potentiation of NKB-induced SLα expression, primary culture of grass carp pituitary cells were 
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challenged with recombinant carp SLα and SLβ , respectively. Our time-course experiment revealed that SLα /
SLβ (30 nM) could both significantly trigger NK3R mRNA expression from 12 hr to 48 hr in a time-dependent 
Figure 1. Synergism between NKBRPa and SLα/β in stimulation of SLα gene expression. (a) Time course 
of NKBRPa (1 μ M), SLα (30 nM), and NKBRPa (1 μ M)+ SLα (30 nM) on SLα mRNA expression in carp 
pituitary cells. (b) Synergistic effect of SLα /β with NKBa and NKBRPa in stimulation of SLα mRNA expression. 
In this experiment, carp pituitary cells were incubated for 24-hr with SLα /β (30 nM) co-treatment with NKBa, 
NKBRPa, and senktide (1 μ M). (c) Effect of SLα concentration (0.01–100 nM) on basal and NKBRPa (1 μ M)-
induced SLα mRNA expression in carp pituitary cells. (d) Effects of NKBRPa concentration (0.1–1000 nM) 
on basal and SLα (30 nM)-induced SLα transcript levels in carp pituitary cells. (e) Synergistic effect of senktide 
(1 μ M) with SLα and SLβ in stimulation of SLα mRNA expression. Receptor specificity for SLα regulation by 
SLα /β with NKBRPa. In this experiment, carp pituitary cells were challenged for 24-hr with SLα (30 nM)+ 
NKBRPa (1 μ M) or SLβ (30 nM)+ NKBRPa (1 μ M) in the presence or absence of NK3R antagonist SB222200 
(10 μ M). After drug treatment, total RNA was isolated for real-time PCR of SLα mRNA. In the data present 
(mean ± SEM), the groups denoted by different letters represent a significant difference at p < 0.05 (ANOVA 
followed by Dunnett’s test).
www.nature.com/scientificreports/
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fashion (Fig. 2a). In parallel dose-dependent studies, a 24-hr incubation with increasing levels of SLα or SLβ 
(0.1–100 nM) also elevated NK3R mRNA expression in a dose-dependent manner (Fig. 2b). To further elucidate 
the signal transduction mechanisms for NK3R regulation by SLs, various pharmacological blockers targeting 
different pathways were recruited. As shown in Fig. 2c, SLα - or SLβ -induced NK3R transcript expression could 
be abolished by simultaneous incubation with the PI3K inhibitor wortmannin (1 μ M), Akt inhibitor HIMOC 
(10 μ M), or mTOR inhibitor rapamycin (20 nM). Similar results were also observed by preventing PI3K activation 
Figure 2. Up-regulation of NK3R gene expression by SLα/β in grass carp pituitary cells. (a) Time course 
of carp SLα (30 nM) and SLβ (30 nM) treatment on NK3R mRNA expression in carp pituitary cells. (b) 24-hr 
incubation with increasing levels of SLα or SLβ (0.01–100 nM) treatment on NK3R mRNA expression in carp 
pituitary cells. (c) Effects of 24-hr co-treatment with the PI3K inhibitor Ly294002(10 μ M) and wortmannin 
(1 μM), Akt inhibitor HIMOC (10 μ M) and mTOR inhibitor rapamycin (20 nM) on SLα (30 nM)- or SLβ 
(30 nM)-induced NK3R transcript expression in carp pituitary cells. (d) Effects of 24-hr co-treatment with 
the JAK2 inhibitor HEX (50 μ M), STAT5 inhibitor IQDMA (50 μ M), MEK1/2 inhibitor U0126 (10 μ M) and p38 
MAPK inhibitor PD169816 (10 μ M) on SLα (30 nM)- or SLβ (30 nM)-induced NK3R mRNA expression. After 
drug treatment, total RNA was isolated for real-time PCR of NK3R mRNA. In the data present (Mean ± SEM), 
the groups denoted by different letters represent a significant difference at p < 0.05 (ANOVA followed by 
Dunnett’s test).
www.nature.com/scientificreports/
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using another PI3K inhibitor Ly294002 (10 μ M; Fig. 2c). Given that SL activation of MAPK cascades has been 
reported in grass carp pituitary cells7, the functional role of MAPK cascades on SL-induced NK3R gene expres-
sion were also tested in carp pituitaries. As shown in Fig. 2d, SLα - or SLβ -induced NK3R mRNA expression were 
found to be sensitive to the blockade by the MEK1/2 inhibitor U-0126 (10 μ M) or p38MAPK inhibitor PD-169816 
(10 μ M). In the parallel experiments, SLα - or SLβ -induced NK3R mRNA expression could be attenuated or 
totally abolished by simultaneous treatment with the JAK2 inhibitor HEX (50 μ M; Fig. 2d), and STAT5 inhibitor 
IQDMA (50 μ M; Fig. 2d), respectively.
Synergistic effects of IGF and SL on NK3R and SLα gene expression. Given our recent studies 
that IGFs and SLs were both found to be effective in stimulating SLα and NK3R gene expression in carp pituitary 
cells7,17, the functional interaction between SLs and IGFs in the regulation of SLα and NK3R gene expression 
were examined in carp pituitary cells. As shown in Fig. 3a, SLα (30 nM) and IGF-I (50 nM) treatment alone could 
both significantly elevate NK3R and SLα mRNA expression in carp pituitary cells in a time-dependent manner. 
Interestingly, the stimulatory effects on NK3R and SLα mRNA expression were significantly enhanced (up to 8 
fold for NK3R and 10 fold for SLα ) especially after 24–48 hr of drug treatment with co-treatment of SLα (30 nM) 
with IGF-I (50 nM). Following the time-course experiment, a single-dose experiment was performed at 24 hr. As 
shown in Fig. 3b, the potentiating effect could still be observed with co-treatment of either SLα (30 nM) or SLβ 
(30 nM) with IGF-I (50 nM) or IGF-II (50 nM), respectively. Besides, the functional interaction between SLα and 
IGF-I was further confirmed by a dose-response reciprocal reverse experiment. In this case, IGF-I-induced NK3R 
and SLα mRNA expression were found to be enhanced in a dose-dependent manner with simultaneous treatment 
with increasing concentrations of SLα (0.01–100 nM; Fig. 3c). The maximal responses occurred at 100 nM SLα 
(9 fold basal for NK3R and 11 fold basal for SLα ). Similar concentration-dependence of the potentiating effect 
was also observed in the reciprocal experiment with co-treatment of SLα (30 nM) with increasing levels of IGF-I 
(0.01–100 nM; Fig. 3d).
Synergistic effects of SLα, IGF-I and NKBRPa on SLα mRNA expression. In the current study, the 
synergism between SL and IGF in stimulation of NK3R mRNA expression was noted in carp pituitary cells. So 
now we have an interesting idea, what will happen when we use a cocktail containing SL, IGF and NKB to chal-
lenge carp pituitary cells ? To answer this question, the cocktail of SLα , IGF-I and NKBRPa was used to test grass 
carp pituitary cells. As shown in Fig. 4a, IGF-I (50 nM), NKBRPa (1 μ M) and SLα (30 nM) treatment alone could 
stimulate SLα mRNA up to 24 hr, however, co-treatment of the three drugs together could significantly elevate 
SLα mRNA from 6 hr (up to 2 fold basal) to 48 hr (up to 20 fold basal). In the single-dose experiment with drug 
treatment fixed at 24 hr, the potentiating effect could still be observed with co-treatment of either SLα (30 nM) 
or SLβ (30 nM) with NKBRPa (1 μ M) and IGF-I (50 nM) (Fig. 4b). To clarify the mechanism responsible for the 
regulation of SLα mRNA expression by SLα /β co-treated with IGF-I and NKBRPa, a pharmacological approach 
was performed in carp pituitary cells. As a first step, NK3R agonist senktide (1 μ M) was recruited to replace the 
NKBRPa in the potentiating study with IGF-I (50 nM) and SLα (30 nM). As shown in Fig. 4c, senktide could 
mimic the synergistic effects of TAC3 gene products on SLα regulation when simultaneous incubation with either 
SLα /SLβ (30 nM) or SLα (30 nM)+ IGF-I (50 nM)/SLβ (30 nM)+ IGF-I (50 nM). Besides, co-treatment with NK3R 
antagonist SB222200 (10 μ M) not only could reduce the stimulatory actions on SLα mRNA expression induced by 
IGF-I (50 nM), NKBRPa (1 μ M) and SLα /SLβ (30 nM) alone, but also markedly suppressed the potentiating effect 
induced by SLα /SLβ + NKBRPa, SLα /SLβ + IGF-I and SLα /SLβ + IGF-I+ NKBRPa (Fig. 4d). These findings, taken 
together, suggested that the synergistic effect of SLα /β , IGF-I and NKBRPa on the stimulation of SLα mRNA 
expression might be mediated through the activation of NK3R, which is a G protein coupled receptor coupled 
with activation of AC/cAMP/PKA, PLC/IP3/PKC, and Ca2+ /CaM/CaMK-II cascades.
To clarify the signal transduction for the synergistic regulation of SLα mRNA expression, various pharmaco-
logical inhibitors/blockers targeting different pathways of NK3R were used. As a first step, the possible involve-
ment of cAMP-dependent pathway was examined at the pituitary cell level. As shown in Fig. 5a, the AC-inhibitor 
MDL12330A (10 μ M) or PKA inhibitor H89 (10 μ M) could block the synergistic effects of SLα , IGF-I and 
NKBRPa on the induction of SLα mRNA expression. To shed light on the role of PLC-dependent cascade in the 
synergistic actions, SLα regulation by SLα , IGF-I and NKBRPa were tested with inhibitors for individual compo-
nents of this pathway. In this case, the synergistic effects of SLα , IGF-I and NKBRPa on SLα gene expression were 
observed to be suppressed/abolished by simultaneous incubation with the PLC inhibitor U73122 (10 μ M) or PKC 
inhibitor GF109203X (10 μ M), respectively (Fig. 5b). To examine the possible role of Ca2+ -dependent cascade in 
SLα regulation by the cocktail containing SLα , IGF-I and NKBRPa, the synergistic effects were also tested with 
various inhibitors for Ca2+ pathway. In this case, this cocktail-induced SLα mRNA expression were found to be 
attenuated/abolished by incubation with Ca2+ free medium or co-treatment with the voltage sensitive calcium 
channel (VSCC) inhibitor nifedipine (10 μ M), respectively (Fig. 5c).
Discussion
At present, except for a single study in carp pituitary cells showing that SLα and SLβ play a stimulatory role in 
autocrine/paracrine regulation of SLα secretion and synthesis in grass carp7, little is known about the functional 
role of SLs at the pituitary level. Since (i) carp SLα and SLβ were found to be effective in triggering SLα secre-
tion, protein production and gene expression in carp SLα cells7, (ii) carp NK3R was specifically expressed in 
SLα cells within the NIL lobe of the carp pituitary14, we speculate that SLs may play a role on NK3R regulation 
at the pituitary level, which may have a functional impact on SLα expression in carp pituitary cells. In the pres-
ent study, using grass carp pituitary cells as a model, we demonstrated for the first time that SLα and SLβ can 
up-regulate NK3R gene expression in time- and dose-dependent manner via direct actions at the pituitary level. 
In fish models, SL receptor has been identified as a member of the Type I GHR family37, and its activation can lead 
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Figure 3. Functional interaction between SL and IGF on the regulation of NK3R and SLα gene expression. 
(a) Time course of carp SLα , IGF-I and SLα + IGF-I on NK3R and SLα mRNA expression. In this experiment, 
carp pituitary cells were incubated from 3 to 48 hr with SLα (30 nM) alone, IGF-I (50 nM) alone and SLα 
(30 nM)+ IGF-I (50 nM). (b) Synergistic effects of SLα /β and IGF-I/-II on the simulation of NK3R and SLα 
mRNA expression. In this case, carp pituitary cells were challenged for 24-hr with SLα or SLβ (30 nM) co-
treatment with either IGF-I or IGF-II (50 nM). (c) Effect of SLα (0.01–100 nM) treatment on basal and IGF-I 
(50 nM)-induced NK3R and SLα mRNA expression in carp pituitary cells. (d) Effects of IGF-I (0.01–100 nM) 
treatment on basal and SLα (30 nM)-induced NK3R and SLα transcript levels in carp pituitary cells. After 
drug treatment, total RNA was isolated for real-time PCR of NK3R and SLα mRNA. In the data present 
(mean ± SEM), the groups denoted by different letters represent a significant difference at p < 0.05 (ANOVA 
followed by Dunnett’s test).
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Figure 4. Functional interactions of SLα/β, IGF-I and NKBRPa/senktide on the regulation of SLα mRNA 
expression. (a) Time course of SLα (30 nM), NKBRPa (1 μ M), IGF-I (50 nM) and SLα (30 nM)+ NKBRPa  
(1 μ M)+ IGF-I (50 nM) treatment on SLα mRNA expression. (b) Synergistic effects of SLα /β with NKBRPa, 
IGF-I or NKBRPa+ IGF-I. In this case, carp pituitary cells were incubated for 24-hr with SLα or SLβ (30 nM) co-
treatment with NKBRPa (1 μ M), IGF-I (50 nM) or NKBRPa (1 μ M)+ IGF-I (50 nM), respectively. (c) Synergistic 
effects of senktide with SLα /β , IGF-I or SLα /β + IGF-I. In this case, carp pituitary cells were incubated for 24-hr 
with senktide (1 μ M) co-treatment with SLα /β (30 nM), IGF-I (50 nM) or SLα /β (30 nM)+ IGF-I (50 nM), 
respectively. (d) Receptor specificity for SLα regulation by SLα or SLβ co-treatment with IGF-I or NKBRPa+ 
IGF-I. In this experiment, carp pituitary cells were incubated for 24-hr with SLα (30 nM)+ IGF-I (50 nM) and 
SLα (30 nM)+ NKBRPa (1 μ M)+ IGF-I (50 nM) or SLβ (30 nM)+ IGF-I (50 nM) and SLβ (30 nM)+ NKBRPa  
(1 μ M)+ IGF-I (50 nM) in the presence or absence of NK3R antagonist SB222200 (10 μ M). After drug treatment, 
total RNA was isolated for real-time PCR of SLα mRNA. In the data present (Mean ± SEM), the groups denoted 
by different letters represent a significant difference at p < 0.05 (ANOVA followed by Dunnett’s test).
www.nature.com/scientificreports/
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to JAK2 recruitment and subsequent activation of STATs, MAPK, and PI3K pathway in grass carp pituitary cells7. 
To test the possible involvement of these signaling cascades in SL-induced NK3R, a pharmacological approach 
using the inhibitors for the respective pathways was used. In carp pituitary cells, the stimulatory effects on NK3R 
mRNA expression induced by SLα or SLβ treatment were either totally abolished or partially suppressed by the 
Figure 5. Functional role of AC/PKA, PLC/PKC and Ca2+ -dependent signaling pathways in the regulation 
of SLα mRNA expression. In this experiment, carp pituitary cells were incubated for 24 hours in the absence 
(control) or presence of (a) AC inhibitor MDL12330A (10 μ M) and PKA inhibitor H89 (10 μ M), (b) PLC 
inhibitor U73122 (10 μ M) and PKC inhibitor (10 μ M), or (c) Ca2+ free medium and VSCC blocker nifedipine 
(10 μ M) in combination of NKBRPa (1 μ M), SLα (30 nM), SLα (30 nM)+ NKBRPa (1 μ M), SLα (30 nM)+ IGF-I 
(50 nM), or SLα (30 nM)+ NKBRPa (1 μ M)+ IGF-I (50 nM). After drug treatment, total RNA was isolated 
for real-time PCR of SLα mRNA. In the data present (mean ± SEM), the groups denoted by different letters 
represent a significant difference at p < 0.05 (ANOVA followed by Dunnett’s test).
www.nature.com/scientificreports/
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JAK2 inhibitor HEX, STAT5 blocker IQDMA, PI3K inhibitors wortmannin and Ly294002, Akt inhibitor HIMOC, 
MEK1/2 blocker U-0126, and P38 MAPK inhibitor PD169816. These results, together with our previous findings 
that SLα and SLβ treatment could trigger rapid phosphorylation of STAT5, Akt, MEK1/2, ERK1/2, MKK3/6, and 
P38 MAPK in carp pituitary cells7, suggest that SL induction of NK3R gene expression at the pituitary cell level is 
mediated through activation of JAK2/STAT5, PI3K/Akt, MEK/ERK1/2, and MKK3/6/P38 MAPK cascades.
In our recent in vitro studies, we have demonstrated that (i) SLα and SLβ could both elevate SLα mRNA 
expression in carp pituitary cells7, and (ii) carp TAC3a gene products, namely NKBa and NKBRPa, could 
up-regulate SLα gene expression via activation of NK3R expressed in the carp pituitary14. In our initial attempt 
of investigate the functional interactions between SLs and TAC3 gene products on SLα expression, we have the 
novel findings that co-treatment of SLα /SLβ with either NKBa or NKBRPa, respectively, could trigger a syner-
gistic effect on SLα mRNA expression in a time- and dose-dependent manner. These potentiating effect could 
be mimicked by replacing TAC3 gene products with the NK3R agonist senktide and blocked by simultaneous 
incubation with the NK3R antagonist SB222200, suggesting the possible dependence of the synergistic effect on 
NK3R expression at the pituitary level. Together with our current finding of SLα /SLβ up-regulation of NK3R gene 
expression in carp pituitary cells, it raises the possibility that SL treatment may enhance the stimulatory effect of 
TAC3 gene products on SLα gene expression by increasing NK3R expression in the carp pituitary. In previous 
studies, the interactions of glucagon with GH have been reported in different species, e.g., in rat38 and grass carp39. 
In rat hepatocytes, cotreatment of glucagon and GH is known to have a potentiating effect on the stimulation 
of IGF-I mRNA expression38. In grass carp, our previous studies have also shown that glucagon could potenti-
ate GH-induced IGF-I gene expression via up-regulation of GHR expression in carp hepatocytes39. Apparently, 
potentiation of the bioactivity of various members of the GH family lineage in fish species can occur by functional 
interactions with GPCR activation by increasing receptor expression mediated the respective stimulating influ-
ence at the cellular level.
In cancer cell models, e.g., pancreatic cancer cells, functional crosstalk of the post-receptor signaling 
between IGF-I/Insulin receptor with GPCR (e.g., neurotensin receptor and type I angiotensin receptor) has been 
reported40. In wound repairing of the rabbit cornea, co-treatment of IGF-I with SP is known to have a potentiating 
effect on the migration of corneal epithelial cells41,42. In our current study with carp pituitary cells, SLα and SLβ 
not only could potentiate SLα mRNA expression induced by TAC3 gene products, but also notably enhance the 
stimulatory effect caused by IGF-I/-II cotreatment on SLα mRNA expression. Interestingly enough, simultaneous 
treatment of carp pituitary cells of SLα /SLβ with IGF-I and NKBRPa was found to markedly increase basal levels 
of SLα mRNA up to 20 fold basal, which was much higher than the corresponding SLα responses induced by SLα 
/SLβ cotreatment with either IGF-I/-II (up to 8 fold basal) or TAC3 gene products NKBa and NKBRPa (up to 8 
fold basal), respectively. This notable increase in the potentiating effect caused by simultaneous treatment of SLα , 
IGF-I and NKBRPa together also occurred with a novel finding in carp pituitary cells, in which cotreatment with 
SLα /SLβ could potentiate the stimulatory effect of IGFs on NK3R gene expression at the pituitary level. Similar 
to our results with SL cotreatment with TAC3 gene products, the highly potent synergistic effect on SLα gene 
expression induced by simultaneous treatment of the three stimulators together could be mimicked by substitut-
ing the NK3R agonist senktide for NKBRPa and blocked by cotreatment with the NK3R antagonist SB222200. 
These findings strongly suggest that the potentiating effect caused by the three SL stimulators is highly depended 
on NK3R expression in the carp pituitary. NK3R is a member of the rhodopsin-type class I type G-protein cou-
pled receptors (GPCRs), and in mammals its activation can trigger intracellular signaling via Go and Gq/1125,43 fol-
lowed by cAMP production44,45, PLC-dependent PI hydrolysis23,24, mobilization of IP3-sensitive intracellular Ca2+ 
([Ca2+ ]i)24 and extracellular Ca2+ ([Ca2+ ]e) entry via voltage-dependent Ca2+ channels25,46. In carp pituitary cells, 
our recent studies have also demonstrated that NKBa/NKBRPa could stimulate SLα gene expression by NK3R 
activation via AC/cAMP/PKA, PLC/IP3/PKC, and Ca2+ /CaM/CaMK-II pathways14. Consistent with these previ-
ous findings, blocking the respective post-receptor signaling pathways using the AC inhibitor MDL12330A, PKA 
inactivator H89, PLC blocker U73122, PKC inhibitor GF109203X, removal of [Ca2+ ]e with a Ca2+ -free culture 
medium, and inactivating voltage-sensitive Ca2+ channel using nifedipine were all effective in inhibiting/blocking 
the highly potent synergistic effect on SLα gene expression caused by simultaneous stimulation with SLα , IGF-I 
and NKBRPa. These results, as a whole, provide evidence that SLα and SLβ can synergize with IGF-I/-II potenti-
ation on SLα gene expression induced by TAC3 gene products by up-regulation of NK3R expression in the carp 
pituitary.
In summary, we have demonstrated for the first time that SLα and SLβ could act at the pituitary cell level to 
potentiate the stimulatory effects of TAC3 gene products and IGF-I/-II on SLα gene expression via up-regulation 
of pituitary NK3R expression. The stimulation on NK3R gene expression probably was mediated through the 
JAK2/STAT5, MAPK and PI3K/Akt cascades. In this study, we also have a novel findings that simultaneous treat-
ment with SL, IGF and TAC3 gene product together could serve as a highly potent stimulatory signal for SLα gene 
expression and this stimulatory effect was dependent on NK3R expression in the carp pituitary and involved the 
activation of post-receptor signaling cascades, namely the AC/cAMP/PKA, PLC/PKC and Ca2+ -dependent path-
ways, coupled to NK3R stimulation. Since SL autoregulation via local release of SLα and SLβ has been recently 
demonstrated in the carp pituitary7. Our findings suggest that SLα and SLβ released at the pituitary level may 
act in an autocrine/paracrine manner to modulate the pituitary sensitivity to the synergistic stimulation on SLα 
expression triggered by IGF-I/-II and TAC3 gene products via up-regulation of NK3R expression in the carp 
pituitary.
Materials and Methods
Animals. One-year-old (1+ ) grass carps (Ctenopharyngodon idellus) with body weight ranging from 2.0 to 
3.0 kg were bought from local markets and maintained in well aerated 250L aquaria at 20 ± 2 °C under a 12L:12D 
photoperiod. Given the carps at this stage are pre-pubertal and sexual dimorphism is not apparent, fish of mixed 
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sexes were used for preparation of pituitary cell cultures. All animal experiments were conducted in accordance 
with the guidelines and approval of the respective Animal Research and Ethics committees of the University of 
Hong Kong and Huazhong Agricultural University.
Reagents. Recombinant proteins of grass carp SLα and SLβ were expressed in E. coli, purified and function-
ally characterized as described previously7. The two hormones were dissolved in PBS and stored frozen at − 80 °C 
as 0.1 mM stocks in small aliquots. Grass carp NKBa and NKBRPa were synthesized from GenScript using the 
automated solid-phase method, and the carboxyl-terminus of individual peptides was amidated. These peptides 
were dissoved in DMSO, and stored frozen at − 80 °C as 1 mM stocks in small aliquots. Human IGF-I and IGF-II 
were purchased from Sigma and dissolved in double-distilled deionized water and stored as 0.1 mM stocks in 
small aliquots at − 80 °C. Pharmacological agents, including MDL12330A, H89, GF109203X, U73122, nifedi-
fine, Ly294002, wortmannin, rapamycin, HIMOC, U0126, PD168916, HEX, and IQDMA were acquired from 
Calbiochem, while senktide and SB222200 were purchased from Tocris. Similar to the peptides, these pharmaco-
logical agents were prepared as a high concentration frozen stock in small aliquots and diluted with pre-warmed 
culture medium to appropriate concentrations 15 min prior to drug treatment.
Primary culture of grass carp pituitary cells. Grass carp pituitary cells were prepared by trypsin/DNase 
digestion method as described previously47. Briefly, pituitaries were excised from grass carp and diced into 
0.5-mm fragments using a McILwain tissue chopper. After 30-min trypsin digestion with constant shaking at 
28 °C, pituitary fragments were suspended in Ca2+ -free MEM supplemented with DNase I (0.01 mg/ml, Sigma). 
Pituitary cells were dispersed by gently trituration and filtered through a sterile nylon mesh (pore size: 20 μ M) to 
remove undigested fragments/debris. After that, the cells were harvested by centrifugation at 1000 rpm for 10 min 
and re-suspended in MEM medium. Total cell yield and percentage viability were estimated by cell counting in 
the presence of trypan blue using a hematocytometer.
Measurement of carp SLα and NK3R mRNA expression. Grass carp pituitary cells were seeded 
in poly-D-lysine coated 24-well culture plates at a density of ~2.5 × 106 /ml/well. On the following day, drug 
treatment was initiated by replacing the old medium with MEM containing appropriate levels of test sub-
stances. After drug treatment, total RNA was extracted from individual well using Trizol and reversely tran-
scribed by Superscript II (50 Unit, Invitrogen). The RT samples obtained were subjected to qPCR using a 
LightCycler SYBR Green I Kit (Roche) with primers specific for grass carp SLα (Forward Primer: 5′-ACCCACT 
GTACTTCAATCTCC-3′ ; Reverse Primer: 5′-CGTCGTAACGATCAAGAGTAG-3′ ) and NK3R (Forward 
Primer: 5′-GCCAAGAGAAAGGTTGTGAAGA-3′; Reverse Primer: 5′-GTGTACATGCTGCTCTGGCG-3′ ), 
respectively. PCR cycling parameters for SLα and NK3R mRNA detection were set at 94 °C for 3 min followed 
by 35 cycles of amplification with denaturation at 94 °C for 30 sec, annealing at 52 °C for SLα mRNA or 56 °C for 
NK3R mRNA for 30 sec, and extension at 72 °C for 30 sec. Signal detection was routinely set for 20 seconds at 
84 °C for SLα and 86 °C for NK3R, respectively. In these studies, serial dilutions of plasmid DNA containing the 
ORF of SLα (GeneBank no: EF372074) and NK3R (GenBank no: JQ254913) cDNA were used as the standards 
for data calibration. Parallel qPCR measurement of β -actin was also conducted in individual experiment to serve 
as the internal control.
Data transformation and statistical analysis. For real-time PCR measurement of NK3R and SLα 
mRNA, standard curves with a dynamic range of ≥ 105 and a correlation coefficient ≥ 0.95 were used for data 
calibration with RotorGene-Q software 1.7 (Qiagen) under unsupervised mode. Since no significant changes 
were noted for β -actin mRNA levels between different experiment groups in our studies, SLα and NK3R mRNA 
data were simply transformed as a percentage of the mean value in the control group without drug treatment 
(as “%Ctrl”). The data presented (as Mean ± SEM) were pooled results from 6–8 separate experiments and 
analyzed with ANOVA followed by Dunnett’s test using Prism 6.0 and differences between groups were consid-
ered as significant at P < 0.05.
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